, Tracking Stock Market Picks
Enter Symbol:

down 88.11 %

CELSION CORP (CLSN) rated Buy with price target $18 by Griffin Securities

Posted on: Thursday,  Aug 16, 2012  8:25 AM ET by Griffin Securities

Griffin Securities rated Buy CELSION CORP (NASDAQ: CLSN) on 08/16/2012, when the stock price was $16.74. Since
then, CELSION CORP has lost 88.11% as of 01/19/2016's recent price of $1.99.
If you would have followed this Griffin Securities's recommendation on CLSN, you would have lost 88.11% of your investment in 1251 days.

Celsion Corporation (Celsion) is an oncology drug development company focused on developing drugs for the treatment of various cancer indications. The Company?s product ThermoDox is evaluated in a Phase III clinical trial for primary liver cancer and a Phase II study for recurrent chest wall breast cancer (RCW). ThermoDox is a liposomal encapsulation of doxorubicin, an oncology drug for the treatment of a range of cancers.

Griffin Securities
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/16/2012 8:25 AM Buy
16.74 81.00
as of 12/31/2012
1 Week down  -3.19 %
1 Month up  9.20 %
3 Months up  50.55 %
1 YTD up  120.16 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy